Lipiodol    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
280Huge arteriovenous malformation with cervicofacial or limb lesion1

280. Huge arteriovenous malformation with cervicofacial or limb lesion    [ 22 clinical trials,   26 drugs,   (DrugBank: 13 drugs),   11 drug target genes,   147 drug target pathways]
Searched query = "Huge arteriovenous malformation with cervicofacial or limb lesion", "Huge arteriovenous malformation", "Arteriovenous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 22 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02625389
(ClinicalTrials.gov)
November 29, 20173/12/2015Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization.Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. A Phase IV Study.Congenital Hemangioma;Hemangioendothelioma;Angiosarcoma;Arteriovenous MalformationDrug: Lipiodol® Ultra Fluid with surgical gluesGuerbetNULLRecruiting18 YearsN/AAll125Phase 4India